Physician profile
Alexander Bitzer
NPI 1821476839
$66,869.40
in general payments reported to CMS, 2019-2025
12 companies · $366 in 2025
The $366 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37.98 · 2020: $45K · 2021: $11K · 2022: $2,102 · 2023: $709 · 2024: $7,140 · 2025: $366.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,200 · Travel and Lodging: $2,599 · Food and Beverage: $1,416.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,200.00 |
| Travel and Lodging | $2,598.58 |
| Food and Beverage | $1,415.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $23,450.20 | 2020-2024 | |
| Lima USA, INC. | $17,500.00 | 2020 | |
| Smith+Nephew, INC. | $13,702.55 | 2020-2025 | Q-Fix, Bone Anchors With Arthroscopic Delivery System, Microraptor |
| Citieffe, INC. | $4,200.00 | 2024 | Humerus, Estremo, Eba One |
| Peerless Surgical INC. | $4,136.12 | 2020-2021 | |
| Mid-Atlantic Surgical Systems, LLC | $1,887.12 | 2021-2025 | |
| Catalyst Orthoscience | $1,300.63 | 2021-2025 | |
| Xiros INC | $278.23 | 2023-2025 | |
| Stryker Corporation | $202.48 | 2021-2023 | T2 Alpha |
| Zimmer Biomet Holdings, INC. | $160.24 | 2020 | |
| Supreme Orthopedic Systems, LLC | $37.98 | 2019 | |
| Tactile Systems Technology INC | $13.85 | 2023 | Entre Plus, Flexitouch Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Bitzer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.